Company Update ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release BSE India Alembic Pharmaceuticals receives UDFDA Final Approval for Fluphenazine Hydrochloride Tablets USP, 1 mg 2.5 mg, 5 mg and 10 mg.